Home >> Research >> Programmes >> Infection Immunity And Inflammation Programme >> Infrastructure & Organisation - III

Infrastructure & Organisation - III

The III theme benefits from vital interfaces with core UCL and UCLH infrastructure, including the UCL Institute of Immunity and Transplantation; Royal Free Hospital; and the UCH Hospital for Tropical Diseases.

The III theme also supports the Wolfson Drug Discovery Unit, part of the world-leading Centre for Amyloidosis and Acute Phase Proteins


Royal Free Hospital

The Royal Free Campus is one UCL Medical School’s main teaching and research sites. Research activity at the Royal Free falling within the III Programme includes:

The UCL Institute of Immunity and Transplantation

The Institute of Immunity and Transplantation is an experimental medicine partnership to bring together world-leading research and clinical trials in a multi-million pound purpose-designed centre at the Royal Free Hospital. Using state of the art experimental platforms in Transplantation and tissue engineering, Vaccination, Cell, and Gene therapy, the Institute will focus on delivery of novel treatments for Cancer, Chronic infection, Autoimmunity and Inherited diseases.

Translational Research Collaborations

Investigators from the III theme are partners in both of the NIHR Office for Clinical Research Infrastructure (NOCRI) Translational Research Collaborations: Joint and Related Inflammatory Diseases, Centre Academic Lead (CAL) Professor David Isenberg; and Inflammatory Respiratory Disease, CAL Dr Jo Porter.

Dr Sarah Watters is the Centre Business Lead for both partnerships.